David Darling

Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma

Yair Lotan, Jay D. Raman, Shahrokh F. Shariat et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 129 citations · Full text

Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study

L. Kavalieris, P.J. O’Sullivan, Chris Frampton et al. · The Journal of Urology · 2016 · 111 citations

A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma

L. Kavalieris, P.J. O’Sullivan, James M. Suttie et al. · BMC Urology · 2015 · 46 citations · Full text

A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets

Vivienne Breen, Nikola Kasabov, Ashish M. Kamat et al. · BMC Medical Research Methodology · 2015 · 32 citations · Full text

Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma

David Darling, Carthika Luxmanan, P.J. O’Sullivan et al. · Advances in Therapy · 2017 · 30 citations · Full text